Child pages
  • Multi-center breast DCE-MRI data and segmentations from patients in the I-SPY 1/ACRIN 6657 trials (ISPY1)

Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Acknowledgements

This shared data set was provided by the Breast Imaging Research Program at UCSF, in collaboration with ACRIN (American College of Radiology Imaging Network), the I-SPY TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and molecular Analysis), and TCIA.

Funding sources include:

UCSFR01 CA132870 and U01 CA151235
ACRINCA079778 and CA080098
I-SPYCA31964 and CA33601

David Newitt, PhD, UCSF
Nola Hylton, PhD, UCSF  

Summary

BACKGROUND

ACRIN 6657 was designed as a prospective study to test MRI for ability to predict response to treatment and risk-of-recurrence in patients with stage 2 or 3 breast cancer receiving neoadjuvant chemotherapy (NACT). ACRIN 6657 was conducted as a companion study to CALGB 150007, a correlative science study evaluating tissue-based biomarkers in the setting of neoadjuvant treatment of breast cancer. Collectively, CALGB 150007 and ACRIN 6657 formed the basis of the multicenter Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and moLecular Analysis (I-SPY TRIAL) breast cancer trial, a study of imaging and tissue-based biomarkers for predicting response and survivalAdd protocol references for all three studies.
Participant Eligibility and Enrollment: Criteria for inclusion were patients enrolling on CALGB 150007 with T3 tumors measuring at least 3 cm in diameter by clinical exam or imaging and receiving neoadjuvant chemotherapy with an  anthracycline-cyclophosphamide regimen alone or followed by a taxane. Pregnant patients and those with ferromagnetic prostheses were excluded from the study. The study was open to enrollment from May 2002 to March 2006. 237 patients were enrolled, of which 230 met eligibility criteria.

...

Collection Statistics

(updated 116/2118/20142015)

Modalities

 MR

Number of Patients

 222

Number of Studies

847

Number of Series

 7920

Number of Images

 386878

Images Size (GB) 

If you are unsure how to download this Collection please view our quick guide on Searching by Collection or refer to our The Cancer Imaging Archive User's Guide for more detailed instructions on using the site.

Shared Lists: See descriptions below under "Curated Data Sets"

...

Imaging Data Transfer Process

...

847 MR on-study studies (222 subjects) in UCSF image database.
One patient in the image data collection (I-SPY ID 1079 ) does not appear in the Feb. 2, 2011 I-SPY FINAL LOCKED clinical data set. So no clinical data is available.

Anchor
Level1DataSet
Level1DataSet
Level 1: LD Dataset

Studies with MRI measured longest diameter
839 MR studies have LD reported in the I-SPY 1 clinical database
834 MR studies (219 subjects) in UCSF image database with LD

5 studies that have LD measurement are missing from
the UCSF and ACRIN TRIAD image data collections:

1071, T1
1138, T1

1101, T3
1040, T4

1187, T4

Anchor
Level2aDataSet
Level2aDataSet
Level 2a: Good SER Volume Dataset – updated 9/3/14

708 MR studies (208 subjects) in UCSF image database

...

  • Patient 1079 does not appear in the Feb. 2, 2011 I-SPY FINAL LOCKED clinical data set. So no clinical data is available.

Anchor
Level2bDataSet
Level2bDataSet
Level 2b: SER Volume Dataset submitted to ACRIN in 2008

707 MR studies (207 subjects) in UCSF image database
Differences between Levels 2a and 2b:

...